Literature DB >> 2567448

Treatment of Parkinson's disease with novel dopamine D2 agonist SK&F 101468.

R Kapoon, Z Pirtosek, J P Frankel, G M Stern, A J Lees, J M Bottomley, N S Haran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2567448     DOI： 10.1016/s0140-6736(89)90146-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Ropinirole (SK and F 101468) in the treatment of Parkinson's disease.

Authors:  B Kleedorfer; G M Stern; A J Lees; J M Bottomley; N Sree-Haran
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

2.  Pharmacokinetics and dose proportionality of D2-agonist MK-458 (HPMC) in parkinsonism.

Authors:  N R Cutler; S A Reines; L F McLean; J J Sramek; A G Porras; E L Hand
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.